A history of adjunctive glucocorticoid treatment for pediatric sepsis: Moving beyond steroid pulp fiction toward evidence-based medicine

Pediatric Critical Care Medicine

Volumn 8, Issue 6, 2007, Pages 530-539

  Zimmerman, Jerry J ^a  

^a UNIVERSITY OF WASHINGTON SCHOOL OF MEDICINE   (United States)

Author keywords

Bacterial meningitis; Children; Corticosteroids; Corticotropin; Cortisol; History of medicine; Hydrocortisone; Pediatric critical care medicine; Sepsis; Septic shock; Thomas Addison

Indexed keywords

CORTICOSTEROID DERIVATIVE; CORTICOTROPIN; CORTISONE; CORTISONE ACETATE; DEXAMETHASONE; ETOMIDATE; FLUDROCORTISONE; GLUCOCORTICOID; HYDROCORTISONE; KETOCONAZOLE; METHYLPREDNISOLONE; PLACEBO; STEROID; STEROID HORMONE; VASOACTIVE AGENT;

ADULT RESPIRATORY DISTRESS SYNDROME; ARTIFICIAL VENTILATION; BACTERIAL INFECTION; BACTERIAL MENINGITIS; CEREBROVASCULAR ACCIDENT; CLINICAL TRIAL; CONGENITAL ADRENAL HYPERPLASIA; CONTROLLED CLINICAL TRIAL; DENGUE; DISEASE ASSOCIATION; DISEASE SEVERITY; DRUG ACTIVITY; DRUG EFFICACY; DRUG MEGADOSE; DRUG SAFETY; DRUG SUBSTITUTION; DRUG WITHDRAWAL; EVIDENCE BASED MEDICINE; GASTROINTESTINAL HEMORRHAGE; HUMAN; HYDROCORTISONE BLOOD LEVEL; INFECTION; INTENSIVE CARE; LOW DRUG DOSE; META ANALYSIS; PRIORITY JOURNAL; RANDOMIZED CONTROLLED TRIAL; REVIEW; RHEUMATIC FEVER; RHEUMATOID ARTHRITIS; SEPSIS; SEPTIC SHOCK; SHOCK; SYSTEMATIC REVIEW; TRAUMATIC BRAIN INJURY; UNSPECIFIED SIDE EFFECT;

EID: 35948976137     PISSN: 15297535     EISSN: None     Source Type: Journal    
DOI: 10.1097/01.PCC.0000288710.11834.E6     Document Type: Review

References (124)

1. Eustachio B: Opuscula Anatomica. Venice, Italy, Vicentius Luchinus, 1563
2. Wehner C: Curriculum Vitae. http://wehner.org/addison/cv/index.htm. Accessed January 10, 2007
3. Jeffcoate W: Thomas Addison: One of the three "giants" of Guy's Hospital. Lancet 2005; 365:1989-1990
4. Addison T: On the Constitutional and Local Effects of Disease of the Supra-Renal Capsules. Baltimore, Williams & Wilkins, 1855
5. Lovas K, Husebye ES: Addison's disease. Lancet 2005; 365:2058-2061
6. Werner C: History of Addison's Disease, 2001. http://wehner.org/addison/ history/index.htm. Accessed January 10, 2007
7. Greenhow E: On Addison's Disease, Being the Croonian Lectures for 1875. London, Lindsay and Blakiston, 1875
8. Brooks B, Blalock A: Shock with particular reference to that due to hemorrhage and trauma to muscles. Ann Surg 1934; 100:728-733
9. Corbett J: The suprarenal gland in shock. JAMA 1915; 65:380-383
10. Sweet J: Surgical shock and some related problems. Am J Med 1918; 155:625-639
11. Hartman FA BK: The hormone of the adrenal cortex. Science 1930; 72:76
12. Swingle WW, Pfiffner JJ: The revival of comatose adrenalectomized cats with an extract of the suprarenal cortex. Science 1930; 72:75-76
13. Swingle W, Pfiffner JJ, Vars HM, et al: Thr function of the adrenal cortical hormone and the cause of death from adrenal insufficiency. Science 1933; 77:58-64
14. Hinshaw LB, Archer LT, Beller-Todd BK, et al: Survival of primates in LD100 septic shock following steroid/antibiotic therapy. J Surg Res 1980; 28:151-170
15. Hinshaw LB, Beller BK, Archer LT, et al: Recovery from lethal Escherichia coli shock in dogs. Surg Gynecol Obstet 1979; 149:545-553
16. Hinshaw LB, Beller BK, Chang AC, et al: Corticosteroid/antibiotic treatment of adrenalectomized dogs challenged with lethal E. coli. Circ Shock 1985; 16:265-277
17. Cushing H: The basophilic adenoma of the pituitary body and their clinical manifestations (pituitary basophilism). Bull Johns Hopkins Hosp 1932; 50:138-195
18. Selye H: A syndrome produced by diverse noxious agents. Nature 1936; 138:32
19. Raju TN: The Nobel chronicles. 1950: Edward Calvin Kendall (1886-1972); Philip Showalter Hench (1896-1965); and Tadeus Reichstein (1897-1996). Lancet 1999; 353:1370
20. Mason HL, Meyers CS, Kendall EC: The chemistry of crystalline substances isolated from the suprarenal gland. J Biol Chem 1936; 114:613-631
21. Sarrett L: A new method for the preparation of 17-alpha-hydroxy- 20ketopregnanes. J Am Chem Soc 1948; 70:1454-1458
22. Hench P, Kendal EC, Slocumb CH, et al: The effect of a hormone of the adrenal cortex (17-hydroxy-11-dehydro-corticosterone: compound E) and of pituitary adrenocorticotropic hormone on rheumatoid arthritis. Mayo Clin Proc 1949; 24:181-197
23. Ebert R, Barclay WR: Changes in connective tissue reaction induced by cortisone. Ann Intern Med 1952; 37:506-518
24. Crigler JF, Silverman SH, Wilkins L: Further studies on the treatment of congenital adrenal hyperplasia with cortisone: IV. Effect of cortisone and compound B in infants with disturbed electrolyte metabolism. Pediatrics 1952; 10:397-413
25. Bartter FC, Albright F, Forbes AP, et al: The effects of adrenocorticotropic hormone and cortisone in the adrenogenital syndrome associated with congenital adrenal hyperplasia: An attempt to explain and correct its disordered hormonal pattern. J Clin Invest 1951; 30:237-251
26. Waterhouse R: A case of suprarenal apoplexy. Lancet 1911; 1:577-578
27. Friderichsen C: Nebennierenapoplexie bei kleinen Kindern. Jahrbuch Kinderheilkunde 1918; 87:109-125
28. Bamatter F: Fulminate Meningokokkensepsis. Zur Atiologie des Syndroms von Waterhouse-Friderichsen. Jarbuch Kinderheilkunde 1934; 142:129-162
29. Friderichsen C: Waterhouse-Friderichsen syndrome. Acta Endocrinol 1955; 18:482-492
30. Hodes HL, Moloshok RE, Markowitz M: Fulminating meningococcemia treated with cortisone: Use of blood eosinophil count as a guide to prognosis and treatment. Pediatrics 1952; 10:138-149
31. Hahn EO, Houser HB, Rammelkamp CH Jr, et al: Effect of cortisone on acute streptococcal infections and poststreptococcal complications. J Clin Invest 1951; 30:274-281
32. Jahn JP, Boling L, Meagher TR, et al: The combination of ACTH-cortisone-hydrocortisone with antibiotics in the management of overwhelmingly severe infections. J Pediatr 1954; 44:640-657
33. Weitzman S, Berger S: Clinical trial design in studies of corticosteroids for bacterial infections. Ann Intern Med 1974; 81:36-42
34. Bennett I, Finland M, Hamburger M, et al: The effectiveness in the management of severe infections. JAMA 1963; 183:462-465
35. Schumer W: Steroids in the treatment of clinical septic shock. Ann Surg 1976; 184:333-341
36. Group CS: The effectiveness of hydrocortisone in the management of severe infections. JAMA 1963; 183:462-465
37. Sprung CL, Caralis PV, Marcial EH, et al: The effects of high-dose corticosteroids in patients with septic shock: A prospective, controlled study. N Engl J Med 1984; 311:1137-1143
38. Bone RC, Fisher CJ Jr, Clemmer TP, et al: A controlled clinical trial of high-dose methylprednisolone in the treatment of severe sepsis and septic shock. N Engl J Med 1987; 317:653-658
39. Effect of high-dose glucocorticoid therapy on mortality in patients with clinical signs of systemic sepsis. The Veterans Administration Systemic Sepsis Cooperative Study Group. N Engl J Med 1987; 317:659-665
40. Sjolin J: High-dose corticosteroid therapy in human septic shock: Has the jury reached a correct verdict? Circ Shock 1991; 35:139-151
41. Lefering R, Neugebauer EA: Steroid controversy in sepsis and septic shock: A metaanalysis. Crit Care Med 1995; 23:1294-1303
42. Cronin L, Cook DJ, Carlet J, et al: Corticosteroid treatment for sepsis: A critical appraisal and meta-analysis of the literature. Crit Care Med 1995; 23:1430-1439
43. Lebel MH, Freij BJ, Syrogiannopoulos GA, et al: Dexamethasone therapy for bacterial meningitis: Results of two double-blind, placebo-controlled trials. N Engl J Med 1988; 319:964-971
44. Odio CM, Faingezicht I, Paris M, et al: The beneficial effects of early dexamethasone administration in infants and children with bacterial meningitis. N Engl J Med 1991; 324:1525-1531
45. Girgis NI, Tribble DR, Sultan Y, et al: Short course chemotherapy with cefixime in children with multidrug-resistant Salmonella typhi Septicaemia. J Trop Pediatr 1995; 41:364-365
46. Kanra GY, Ozen H, Secmeer G, et al: Beneficial effects of dexamethasone in children with pneumococcal meningitis. Pediatr Infect Dis J 1995; 14:490-494
47. Schaad UB, Lips U, Gnehm HE, et al: Dexamethasone therapy for bacterial meningitis in children. Swiss Meningitis Study Group. Lancet 1993; 342:457-461
48. McIntyre PB, Berkey CS, King SM, et al: Dexamethasone as adjunctive therapy in bacterial meningitis: A meta-analysis of randomized clinical trials since 1988. JAMA 1997; 278:925-931
49. van de Beek D, de Gans J, McIntyre P, et al: Corticosteroids in acute bacterial meningitis. Cochrane Database Syst Rev 2003; CD004405
50. Committee on Infectious Diseases: Red Book 2006. Report of the Committee on Infectious Diseases. 27th Edition. Elk Grove Village, IL, American Academy of Pediatrics, 2006
51. Zaloga GP, Marik P: Hypothalamic-pituitary-adrenal insufficiency. Crit Care Clin 2001; 17:25-41
52. Baldwin WA, Allo M: Occult hypoadrenalism in critically ill patients. Arch Surg 1993; 128:673-676
53. Shenker Y, Skatrud JB: Adrenal insufficiency in critically ill patients. Am J Respir Crit Care Med 2001; 163:1520-1523
54. Marik PE, Zaloga GP: Adrenal insufficiency in the critically ill: A new look at an old problem. Chest 2002; 122:1784-1796
55. Cooper MS, Stewart PM: Corticosteroid insufficiency in acutely ill patients. N Engl J Med 2003; 348:727-734
56. Soni A, Pepper GM, Wyrwinski PM, et al: Adrenal insufficiency occurring during septic shock: Incidence, outcome, and relationship to peripheral cytokine levels. Am J Med 1995; 98:266-271
57. Bouachour G, Tirot P, Gouello JP, et al: Adrenocortical function during septic shock. Intensive Care Med 1995; 21:57-62
58. Annane D, Sebille V, Troche G, et al: A 3-level prognostic classification in septic shock based on cortisol levels and cortisol response to corticotropin. JAMA 2000; 283:1038-1045
59. Schroeder S, Wichers M, Klingmuller D, et al: The hypothalamic-pituitary- adrenal axis of patients with severe sepsis: Altered response to corticotropin-releasing hormone. Crit Care Med 2001; 29:310-316
60. Marik PE, Zaloga GP: Adrenal insufficiency during septic shock. Crit Care Med 2003; 31:141-145
61. Riordan FA, Thomson AP, Ratcliffe JM, et al: Admission cortisol and adrenocorticotrophic hormone levels in children with meningococcal disease: Evidence of adrenal insufficiency? Crit Care Med 1999; 27:2257-2261
62. Hatherill M, Tibby SM, Hilliard T, et al: Adrenal insufficiency in septic shock. Arch Dis Child 1999; 80:51-55
63. Bone M, Diver M, Selby A, et al: Assessment of adrenal function in the initial phase of meningococcal disease. Pediatrics 2002; 110:563-569
64. Menon K, Clarson C: Adrenal function in pediatric critical illness. Pediatr Crit Care Med 2002; 3:112-116
65. Pizarro CF, Troster EJ, Damiani D, et al: Absolute and relative adrenal insufficiency in children with septic shock. Crit Care Med 2005; 33:855-859
66. van Woensel JB, Biezeveld MH, Alders AM, et al: Adrenocorticotropic hormone and cortisol levels in relation to inflammatory response and disease severity in children with meningococcal disease. J Infect Dis 2001; 184:1532-1537
67. De Kleijn ED, Joosten KF, Van Rijn B, et al: Low serum cortisol in combination with high adrenocorticotrophic hormone concentrations are associated with poor outcome in children with severe meningococcal disease. Pediatr Infect Dis J 2002; 21:330-336
68. Önebli-Mungan NYD, Yildisdaz D, Yapicioglu H, et al: Growth hormone, and insulin-like growth factor 1 levels and their relation to survival in children with bacterial sepsis and septic shock. J Paediatr Child Health 2004; 40:221-226
69. Sarthi M, Lodha R, Vivekananhan S, et al: Adrenal status in children with septic shock using low dose stimulation test. Pediatr Crit Care Med 2007; 8:23-28
70. Annane DBE: Corticosteroids for patients with septic shock. JAMA 2003; 289:43-44
71. Hamrahian AH, Oseni TS, Arafah BM: Measurements of serum free cortisol in critically ill patients. N Engl J Med 2004; 350:1629-1638
72. Annane D, Maxime V, Ibrahim F, et al: Diagnosis of adrenal insufficiency in severe sepsis and septic shock. Am J Respir Crit Care Med 2006; 174:1319-1326
73. Loriax L: Glucocorticoid therapy in the intensive care unit. N Engl J Med 2004; 350:1601-1602
74. Annane D, Bellissant E, Sebille V, et al: Impaired pressor sensitivity to noradrenaline in septic shock patients with and without impaired adrenal function reserve. Br J Clin Pharmacol 1998; 46:589-597
75. Hoen S, Mazoit JX, Asehnoune K, et al: Hydrocortisone increases the sensitivity to alpha1-adrenoceptor stimulation in humans following hemorrhagic shock. Crit Care Med 2005; 33:2737-2743
76. Bollaert PE, Charpentier C, Levy B, et al: Reversal of late septic shock with supraphysiologic doses of hydrocortisone. Crit Care Med 1998; 26:645-650
77. Briegel J, Forst H, Haller M, et al: Stress doses of hydrocortisone reverse hyperdynamic septic shock: A prospective, randomized, double-blind, single-center study. Crit Care Med 1999; 27:723-732
78. Annane D, Sebille V, Charpentier C, et al: Effect of treatment with low doses of hydrocortisone and fludrocortisone on mortality in patients with septic shock. JAMA 2002; 288:862-871
79. Keh D, Sprung CL: Use of corticosteroid therapy in patients with sepsis and septic shock: An evidence-based review. Crit Care Med 2004; 32:S527-S533
80. Oppert M, Schindler R, Husung C, et al: Low-dose hydrocortisone improves shock reversal and reduces cytokine levels in early hyperdynamic septic shock. Crit Care Med 2005; 33:2457-2464
81. Palencia E: Hidrocortisona en el shock séptico: Primeros resultados del CORTICUS. Revista Electronica de Medicina Intensiva ISICEM 1982; 6:A43
82. Yildiz O, Doganay M, Aygen B, et al: Physiological-dose steroid therapy in sepsis [ISRCTN36253388]. Crit Care 2002; 6:251-259
83. Midgeon CJ, Kenny FM, Hung W, et al: Study of adrenal function in children with meningitis. Pediatrics 1967; 40:163-183
84. Zachmann ML, Fanconi A, Prader A: Plasma cortisol in children with fulminating meningococcal infection. Helvet Paediatr Acta 1974; 29:245-250
85. Annane D: Cortisol replacement for severe sepsis and septic shock: What should I do? Crit Care 2002; 6:190-191
86. den Brinker M, Joosten KF, Liem O, et al: Adrenal insufficiency in meningococcal sepsis: Bioavailable cortisol levels and impact of interleukin-6 levels and intubation with etomidate on adrenal function and mortality. J Clin Endocrinol Metab 2005; 90:5110-5117
87. Annane D: Etomidate and intensive care physicians. Intensive Care Med 2005; 31:1454
88. Annane D: ICU physicians should abandon the use of etomidate! Intensive Care Med 2005; 31:325-326
89. Jackson WL Jr: Should we use etomidate as an induction agent for endotracheal intubation in patients with septic shock? A critical appraisal. Chest 2005; 127:1031-1038
90. Hadassah Medical Organization ESoICM, International Sepsis Forum, The Gorham Foundation. Corticosteroid Therapy of Septic Shock-Corticus. Available at: http://clinicaltrials.gov/ct/show/nct00147004. Accessed October 1, 2007
91. Sprung CL: CORTICUS Study Group. CORTICUS. Lancet, In Press
92. Burry LD, Wax RS: Role of corticosteroids in septic shock. Ann Pharmacother 2004; 38:464-472
93. Minneci PC, Deans KJ, Banks SM, et al: Meta-analysis: The effect of steroids on survival and shock during sepsis depends on the dose. Ann Intern Med 2004; 141:47-56
94. Annane D, Bellissant E, Bollaert PE, et al: Corticosteroids for severe sepsis and septic shock: A systematic review and metaanalysis. BMJ 2004; 329:485-484
95. Dellinger RP, Carlet JM, Masur H, et al: Surviving Sepsis Campaign guidelines for management of severe sepsis and septic shock. Crit Care Med 2004; 32:858-873
96. Annane D, Bellissant E, Bollaert PE, et al: Corticosteroids for treating severe sepsis and septic shock. Cochrane Database Sys Rev 2004; 1:CD002243
97. Min MUT, Aye M, Shwe TN, et al: Hydrocortisone in the management of dengue shock syndrome. Southeast Asian J Trop Med Public Health 1975; 6:573-579
98. Futrakul P, Poshyachinda M, Mitrakul C, et al: Hemodynamic response to high-dose methyl prednisolone and mannitol in severe dengue-shock patients unresponsive to fluid replacement. Southeast Asian J Trop Med Public Health 1987; 18:373-379
99. Sumarmo D, Talogo W, Asrin A, Isnuhandojo B, et al: Failure of hydrocortisone to affect outcome in dengue shock syndrome. Pediatrics 1982; 69:45-49
100. Tassniyom S, Vasanawathana S, Chirawatkul A, et al: Failure of high-dose methylprednisolone in established dengue shock syndrome: A placebo-controlled, doubleblind study. Pediatrics 1993; 92:111-115
101. Slusher T, Gbadero D, Howard C, et al: Randomized, placebo-controlled, double blinded trial of dexamethasone in African children with sepsis. Pediatr Infect Dis J 1996; 15:579-583
102. Markovitz BP, Goodman DM, Watson RS, et al: A retrospective cohort study of prognostic factors associated with outcome in pediatric severe sepsis: What is the role of steroids? Pediatr Crit Care Med 2005; 6:270-274
103. Zimmerman J, Barker R, Cantini C: Effect of adjunctive corticosteroids on clinical outcomes in pediatric sepsis syndrome. Abstr 461. Crit Care Med 2006; 34(Suppl):A129
104. Morel J, Venet C, Donati Y, et al: Adrenal axis function does not appear to be associated with hemodynamic improvement in septic shock patients systematically receiving glucocorticoid therapy. Intensive Care Med 2006; 32:1184-1190
105. Rady MY, Johnson DJ, Patel B, et al: Cortisol levels and corticosteroid administration fail to predict mortality in critical illness: The confounding effects of organ dysfunction and sex. Arch Surg 2005; 140:661-668
106. Britt RC, Devine A, Swallen KC, et al: Corticosteroid use in the intensive care unit: At what cost? Arch Surg 2006; 141:145-149
107. Stark AR, Carlo WA, Tyson JE, et al: Adverse effects of early dexamethasone in extremely-low-birth-weight infants. National Institute of Child Health and Human Development Neonatal Research Network. N Engl J Med 2001; 344:95-101
108. van den Berghe G, Wouters P, Weekers F, et al: Intensive insulin therapy in the critically ill patients. N Engl J Med 2001; 345:1359-1367
109. Vanhorebeek I, Peeters RP, Vander Perre S, et al: Cortisol response to critical illness: Effect of intensive insulin therapy. J Clin Endocrinol Metab 2006; 91:3803-3813
110. Faustino EV, Apkon M: Persistent hyperglycemia in critically ill children. J Pediatr 2005; 146:30-34
111. Srinivasan V, Spinella PC, Drott HR, et al: Association of timing, duration, and intensity of hyperglycemia with intensive care unit mortality in critically ill children. Pediatr Crit Care Med 2004; 5:329-336
112. Van den Berghe G: How does blood glucose control with insulin save lives in intensive care? J Clin Invest 2004; 114:1187-1195
113. Kothadia JM, O'Shea TM, Roberts D, et al: Randomized placebo-controlled trial of a 42-day tapering course of dexamethasone to reduce the duration of ventilator dependency in very low birth weight infants. Pediatrics 1999; 104:22-27
114. Edwards P, Arango M, Balica L, et al: Final results of MRC CRASH, a randomised placebo-controlled trial of intravenous corticosteroid in adults with head injury-outcomes at 6 months. Lancet 2005; 365:1957-1959
115. Steinberg KP, Hudson LD, Goodman RB, et al: Efficacy and safety of corticosteroids for persistent acute respiratory distress syndrome. N Engl J Med 2006; 354:1671-1684
116. Hildebrandt T, Mansour M, Al Samsam R: The use of steroids in children with septicemia: Review of the literature and assessment of current practice in PICUs in the UK. Paediatr Anaesth 2005; 15:358-365
117. Menon K, Lawson M: Identification of adrenal insufficiency in pediatric critical illness. Pediatr Crit Care Med 2007; 8:276-278
118. Czaja A, Zimmerman JJ: Endpoints/treatment algorithms for RCTs of steroids in pediatric sepsis. Abstr 458. Crit Care Med 2004; 32:A127
119. Curley MA, Zimmerman JJ: Alternative outcome measures for pediatric clinical sepsis trials. Pediatr Crit Care Med 2005; 6:S150-S156
120. Rivers E, Nguyen B, Havstad S, et al: Early goal-directed therapy in the treatment of severe sepsis and septic shock. N Engl J Med 2001; 345:1368-1377
121. Han YY, Carcillo JA, Dragotta MA, et al: Early reversal of pediatric-neonatal septic shock by community physicians is associated with improved outcome. Pediatrics 2003; 112:793-799
122. Ranjit S, Kissoon N, Jayakumar I: Aggressive management of dengue shock syndrome may decrease mortality rate: A suggested protocol. Pediatr Crit Care Med 2005; 6:412-419
123. Bakker J, Grover R, McLuckie A, et al: Administration of the nitric oxide synthase inhibitor NG-methyl-L-arginine hydrochloride (546C88) by intravenous infusion for up to 72 hours can promote the resolution of shock in patients with severe sepsis: Results of a randomized, double-blind, placebo-controlled multicenter study (study no. 144-002). Crit Care Med 2004; 32:1-12
124. Lopez A, Lorente JA, Steingrub J, et al: Multiple-center, randomized, placebocontrolled, double-blind study of the nitric oxide synthase inhibitor 546C88: Effect on survival in patients with septic shock. Crit Care Med 2004; 32:21-30